During the past decade, Okayama University Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Okayama University Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Okayama University Hospital" are "Prostate Cancer" (1 trials) and "Small-Cell-Lung Cancer" (1 trials). Many other conditions were trialed in "Okayama University Hospital" in a lesser frequency.

Most popular intervention types in "Okayama University Hospital" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etoposide and cisplatin after chemoradiotherapy" (1 trials), "Irinotecan and cisplatin after chemoradiotherapy" (1 trials), "endocrine therapy" (1 trials) and "radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Okayama University Hospital" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Okayama University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Okayama University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Okayama University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".